These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 2824221

  • 1. MK-801 stimulates the release of adrenocorticotrophin but not does affect the release of prolactin in the rat.
    Pechnick RN, George R, Poland RE.
    Eur J Pharmacol; 1987 Sep 11; 141(2):323-4. PubMed ID: 2824221
    [No Abstract] [Full Text] [Related]

  • 2. Characterization of the effects of the acute and repeated administration of MK-801 on the release of adrenocorticotropin, corticosterone and prolactin in the rat.
    Pechnick RN, George R, Poland RE.
    Eur J Pharmacol; 1989 May 19; 164(2):257-63. PubMed ID: 2547636
    [Abstract] [Full Text] [Related]

  • 3. The novel anticonvulsant MK-801: a potent and specific ligand of the brain phencyclidine/sigma-receptor.
    Sircar R, Rappaport M, Nichtenhauser R, Zukin SR.
    Brain Res; 1987 Dec 01; 435(1-2):235-40. PubMed ID: 2827853
    [Abstract] [Full Text] [Related]

  • 4. Biochemical and behavioral effects of sigma and PCP ligands.
    Contreras PC, Contreras ML, O'Donohue TL, Lair CC.
    Synapse; 1988 Dec 01; 2(3):240-3. PubMed ID: 2850629
    [Abstract] [Full Text] [Related]

  • 5. The novel anticonvulsant MK-801 interacts with central phencyclidine recognition sites in rat brain.
    Loo PA, Braunwalder AF, Williams M, Sills MA.
    Eur J Pharmacol; 1987 Mar 17; 135(2):261-3. PubMed ID: 3034630
    [No Abstract] [Full Text] [Related]

  • 6. Electrophysiological effects of selective sigma-receptor agonists, antagonists, and the selective phencyclidine receptor agonist MK-801 on midbrain dopamine neurons.
    Steinfels GF, Tam SW, Cook L.
    Neuropsychopharmacology; 1989 Sep 17; 2(3):201-8. PubMed ID: 2571340
    [Abstract] [Full Text] [Related]

  • 7. Differentiation of phencyclidine and sigma receptor types affecting the central inspiratory termination mechanism in cat.
    Foutz AS, Denavit-Saubié M.
    Life Sci; 1989 Sep 17; 45(14):1285-92. PubMed ID: 2554082
    [Abstract] [Full Text] [Related]

  • 8. Interactions of phencyclidine receptor agonist MK-801 with dopaminergic system: regional studies in the rat.
    Rao TS, Kim HS, Lehmann J, Martin LL, Wood PL.
    J Neurochem; 1990 Apr 17; 54(4):1157-62. PubMed ID: 2156013
    [Abstract] [Full Text] [Related]

  • 9. Comparative electroencephalographic and behavioral effects of phencyclidine, (+)-SKF-10,047 and MK-801 in rats.
    Marquis KL, Paquette NC, Gussio RP, Moreton JE.
    J Pharmacol Exp Ther; 1989 Dec 17; 251(3):1104-12. PubMed ID: 2557412
    [Abstract] [Full Text] [Related]

  • 10. Drugs acting on sigma and phencyclidine receptors: a review of their nature, function, and possible therapeutic importance.
    Junien JL, Leonard BE.
    Clin Neuropharmacol; 1989 Oct 17; 12(5):353-74. PubMed ID: 2558790
    [No Abstract] [Full Text] [Related]

  • 11. Sigma and PCP receptors in human frontal cortex membranes.
    Tam SW, Zhang AZ.
    Eur J Pharmacol; 1988 Sep 23; 154(3):343-4. PubMed ID: 2853061
    [No Abstract] [Full Text] [Related]

  • 12. Characterization of the effects of the acute and chronic administration of phencyclidine on the release of adrenocorticotropin, corticosterone and prolactin in the rat: evidence for the differential development of tolerance.
    Pechnick RN, George R, Poland RE, Hiramatsu M, Cho AK.
    J Pharmacol Exp Ther; 1989 Aug 23; 250(2):534-40. PubMed ID: 2547936
    [Abstract] [Full Text] [Related]

  • 13. Multiple receptor types in opioid discrimination.
    Holtzman SG.
    NIDA Res Monogr; 1986 Aug 23; 71():109-26. PubMed ID: 3025731
    [No Abstract] [Full Text] [Related]

  • 14. MK-801 protects the neonatal brain from hypoxic-ischemic damage.
    McDonald JW, Silverstein FS, Johnston MV.
    Eur J Pharmacol; 1987 Aug 21; 140(3):359-61. PubMed ID: 2820765
    [No Abstract] [Full Text] [Related]

  • 15. Modulation of brain NMDA receptors: common mechanism of sigma/PCP receptors and their exogenous and endogenous ligands.
    Sircar R, Samaan H, Nichtenhauser R, Snell LD, Johnson KM, Rivier J, Vale W, Zukin RS, Zukin SR.
    NIDA Res Monogr; 1986 Aug 21; 75():157-60. PubMed ID: 2828962
    [Abstract] [Full Text] [Related]

  • 16. Quantitative conformational analyses predict distinct receptor sites for PCP-like and sigma drugs.
    Manallack DT, Beart PM.
    Eur J Pharmacol; 1987 Dec 01; 144(2):231-5. PubMed ID: 2830125
    [Abstract] [Full Text] [Related]

  • 17. Differences in results from in vivo and in vitro studies on the use-dependency of N-methylaspartate antagonism by MK-801 and other phencyclidine receptor ligands.
    Davies SN, Martin D, Millar JD, Aram JA, Church J, Lodge D.
    Eur J Pharmacol; 1988 Jan 12; 145(2):141-51. PubMed ID: 2832187
    [Abstract] [Full Text] [Related]

  • 18. Interactions of sigma and phencyclidine receptor ligands with the norepinephrine uptake carrier in both rat brain and rat tail artery.
    Massamiri T, Duckles SP.
    J Pharmacol Exp Ther; 1991 Feb 12; 256(2):519-24. PubMed ID: 1847198
    [Abstract] [Full Text] [Related]

  • 19. Neurobiology. Taking apart NMDA receptors.
    Foster AC, Fagg GE.
    Nature; 1991 Feb 12; 329(6138):395-6. PubMed ID: 2443852
    [No Abstract] [Full Text] [Related]

  • 20. Differential effects of sigma and phencyclidine receptor ligands on learning.
    Jones KW, Bauerle LM, DeNoble VJ.
    Eur J Pharmacol; 1990 Apr 10; 179(1-2):97-102. PubMed ID: 2163853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.